HAMSYL Junior is the first-of-its-kind paediatric pack size of pegaspargase. This is an essential milestone in advancing paediatric cancer care for Indian children suffering from an orphan disease called Acute Lymphoblastic Leukaemia (ALL).

HAMSYL Junior has the same composition as Hamsyl, but with a 1500 IU pack size and 2 mL fill volume. HAMSYL Junior ensures precise dosing for children with ALL, while retaining the same API strength (750 IU/mL) in a specifically designed pack. It offers a cost-effective treatment with minimum wastage, eliminating the need for vial sharing.